A phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)

Project Details

Short titleA phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)
StatusActive
Effective start/end date21/10/1531/05/23

Funding

  • MERCK LIMITED

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.